Buy These 2 Cheap Biotech Stocks This Week (The Market Cap)

If you are unable to see the message below, click here to view.

You are receiving this newsletter as an opt-in subscriber of Investors Alley. Ensure you continue to get this valuable content by whitelisting us - click here to learn how. Follow these links to update your subscriber profile or opt-out of these emails.

Wednesday, January 7, 2015 Contact  |  Privacy

IN TODAY'S ISSUE: Under $7 Stock with a 14% Yield and 2 Cheap Biotech Stocks to Buy

Triple and Quadruple-Digit Returns in Marijuana Stocks Are Happening Now! To invest or not to invest in marijuana is NO LONGER the question! The only question savvy investors are asking about marijuana is which company stock is the best to invest in - and that stock could be Chuma Holdings, INC. (CHUM). Click Here to Read the Free Full Report

Buy These 2 Cheap Biotech Stocks This Week By Bret Jensen, Editor of Small Cap Gems I write about the small cap biotech space often on Real Money Pro, SeekingAlpha and as editor of Small Cap Gems. One of the frequently asked questions I get is what do I look for when identifying and purchasing "off the radar" small cap stocks, especially in the biotech sector. This is probably due to the huge winners I have identified in this space over the past six months including multi-baggers like Avanir Pharmaceuticals (Nasdaq: AVNR) and TetraPhase Pharmaceuticals (Nasdaq: TTPH). This makes sense as nothing can provide the returns of investing in a small cap biotech or biopharma company that becomes a much bigger concern in these spaces. Just two decades ago Gilead Sciences (Nasdaq: GILD) was just another small cap equity. It is now a biotech juggernaut whose market capitalization is north of $150 billion and has returned over 14,000% in 20 years (that’s not a typo). When I scout for under-followed small cap stocks within these areas, I look for a couple of things. I want to see a company I believe is undervalued. I want an entity that can execute well against its game plan and has potentially lucrative growth prospects or could be a buyout candidate given the heavy amount of M&A activity in this space currently. Finally, I need to see a positive catalyst(s) that I feel could be a prelude to the stock going much higher. Here are a couple of attractive plays in this sector that could move up in January on positive events. Click to continue reading Buy This Dividend Stock Under $7 for a 14% Yield By Tim Plaehn, Editor of The Dividend Hunter The drop in the price of crude oil over the last quarter of 2014 was and continues to be bad news for companies that drill and own oil wells. In the jargon of the energy sector, these companies operate in the upstream portion of the spectrum from oil in the ground to gas in your car or electric power in your home. Click Here to discover Bret Jensen's #1 Small Cap Stealth Rocket for 2015 [ad] The revenues of upstream energy companies are directly tied to the energy commodity prices. In the master limited partnership, MLP, subsector of the energy sector, the upstream MLPs are focused on owning producing oil wells and generating a steady stream of cash flow to pay high distribution yields to investors - in MLP terms called unit holders with a partnership. The upstream MLPs use oil and gas derivative contracts to hedge or lock in the prices they will receive for a large portion of planned future oil and gas production. These hedging practices have allowed the upstream MLPs to pay steady distributions even as crude oil and natural gas prices fluctuate. Click to continue reading

© Copyright 1998-2015, Investors Alley Corp. All rights reserved. See Privacy Policy and Terms of Use | Contact Us

 

If you enjoyed reading this email, click here to forward it to a friend or colleague.

You are receiving this message because you registered ignoble.experiment@arconati.us through INO.com Invite Sell - Apr 2014.
Click here to send us comments or questions regarding this mailing. Unsubscribe/update profile using link below.

This message from Investors Alley Corp. is being sent in full accordance with the CAN-SPAM Act.
We respect your privacy and, therefore, this email was sent directly from Investors Alley.  Please review our Privacy Statement and Terms of Use. 
If you no longer wish to receive emails from Investors Alley, please opt-out using the link below.

The opinions in this email and corresponding web sites are neither an offer nor a recommendation to buy or sell any security. Investors Alley Corp. and its affiliates may hold a position in any of the companies mentioned.  Investors Alley Corp. is not a registered investment firm nor a broker/dealer.  We urge you to always conduct your own research and due diligence and obtain professional advice before making any investment decision.

All information contained herein is copyright 2014, Investors Alley Corp.
Investors Alley Corporation | 41 Madison Avenue | 31st Floor | New York, NY  10010

Update Your Profile Information | Modify Subscription Settings or Unsubscribe From Emails